Ondine Biomedical, Inc. (GB:OBI) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Ondine Biomedical Inc. successfully held its Annual General Meeting on June 28, 2024, with all proposed resolutions passed unanimously, signaling strong support from the shareholders. As a leader in light-activated antimicrobial therapies, the company continues to advance its photodisinfection technology with multiple products in development and a nasal photodisinfection system that has received international approvals and is undergoing clinical trials in the US.
For further insights into GB:OBI stock, check out TipRanks’ Stock Analysis page.